This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Termination of Life on Request and Assisted Suicide (Review Procedures) Act | |
|---|---|
| Name | Termination of Life on Request and Assisted Suicide (Review Procedures) Act |
| Enacted by | States General of the Netherlands |
| Citation | Dutch statute |
| Enacted | 2002 |
| Status | in force |
Termination of Life on Request and Assisted Suicide (Review Procedures) Act. The Act is a statutory framework enacted by the States General to regulate physician‑assisted dying in the Netherlands, establishing review procedures, oversight bodies, and legal criteria. It translated judicial developments from decisions of the Supreme Court of the Netherlands and debates involving figures such as Jan Peter Balkenende into codified safeguards used alongside institutions like the Royal Dutch Medical Association and the Healthcare Inspectorate. The law interacts with European jurisprudence including rulings by the European Court of Human Rights and comparative frameworks in jurisdictions such as Switzerland, Belgium, and Canada.
The Act followed decades of public debate in the Netherlands influenced by cases adjudicated in the Supreme Court of the Netherlands, policy reports from the Ministry of Health, Welfare and Sport (Netherlands), and advocacy by organizations like the Right to Die Netherlands and the Royal Dutch Medical Association. Parliamentary deliberations in the Dutch House of Representatives and the Dutch Senate reflected influences from legal scholars connected to Leiden University, bioethicists active at Utrecht University, and comparative studies referencing laws in Oregon and rulings in the European Court of Human Rights. The statute was enacted to provide clarity after prosecutorial decisions and landmark cases that involved practitioners in municipalities such as The Hague and Amsterdam.
The Act defines core terms and limits including criteria for eligible patients, the meaning of “unbearable suffering,” and distinctions between withholding treatment and an active end‑of‑life intervention, with influence from ethical analysis at Erasmus University Rotterdam. Definitions draw on medical classifications used in hospitals affiliated with Leiden University Medical Center and policy guidance from the Royal Dutch Medical Association. The statute specifically addresses requests by adults and contemplates provisions that intersect with reproductive and geriatric care provided in institutions such as Nijmegen Radboud University Medical Center and long‑term care facilities in provinces like North Holland.
The Act established regional review committees composed of physicians, ethicists, and jurists modeled after advisory structures found in reports from The Hague Institute for Global Justice and input from the Healthcare Inspectorate. Committees review notifications of physician‑assisted deaths and assess compliance with statutory criteria; their operations echo oversight mechanisms comparable to commissions reviewed in studies at Tilburg University and case law considered by the Supreme Court of the Netherlands. Oversight includes coordination with municipal prosecutors in jurisdictions such as Rotterdam and reporting channels to national bodies in The Hague.
Legislated criteria require that requests be voluntary, well‑considered, and persistent, that the patient be experiencing unbearable suffering with no prospect of improvement, and that all reasonable alternatives have been discussed—standards informed by ethical analyses from Maastricht University and precedent in decisions referenced by the Supreme Court of the Netherlands. Safeguards mandate second opinions from independent physicians associated with centers such as VU University Medical Center and consultation processes resembling models analyzed in comparative law scholarship from Oxford University and McGill University.
Physicians, particularly specialists and general practitioners affiliated with institutions like Amsterdam UMC and university hospitals, bear duties to assess competence, inform patients about palliative options, and document deliberations in medical records consistent with guidance from the Royal Dutch Medical Association. The Act delineates the responsibilities of consultants, nursing staff in facilities such as Elderly Care Homes in the Netherlands, and pharmacists involved in medication supply, aligning clinical protocols with standards discussed at conferences hosted by WHO regional experts and bioethics centers at Harvard Medical School and University of Toronto.
Mandatory notification of each assisted death to regional review committees generates data compiled for national analyses by research institutes including Netherlands Institute for Health Services Research and university centers at Erasmus University Rotterdam. Documentation standards require detailed records of patient requests, consultations, and performed procedures, facilitating studies comparable to those published in journals that collaborate with researchers at Leiden University Medical Center and Utrecht University.
Since enactment, the Act has been the subject of litigation brought to the Supreme Court of the Netherlands and referenced in applications to the European Court of Human Rights; legislative refinements have followed policy evaluations led by the Ministry of Health, Welfare and Sport (Netherlands), petitions by advocacy groups such as Right to Die Netherlands, and academic impact studies from Maastricht University and Tilburg University. Comparative impact assessments cite experiences in Belgium, Switzerland, Canada, and Oregon to inform debates on safeguards, conscientious objection protections, and statistical effects on end‑of‑life care.
Category:Dutch law Category:Medical ethics Category:End-of-life